X
Xuran Wang
Researcher at Carnegie Mellon University
Publications - 11
Citations - 717
Xuran Wang is an academic researcher from Carnegie Mellon University. The author has contributed to research in topics: CRISPR & Gene. The author has an hindex of 5, co-authored 10 publications receiving 367 citations. Previous affiliations of Xuran Wang include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Bulk tissue cell type deconvolution with multi-subject single-cell expression reference
TL;DR: A new method for estimating cell type proportions from bulk tissue RNA-seq data guided by multi-subject single-cell expression reference, which enables the characterization of cellular heterogeneity of complex tissues for understanding of disease mechanisms.
Journal ArticleDOI
APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease
Aivi T. Nguyen,Kui Wang,Kui Wang,Gang Hu,Gang Hu,Xuran Wang,Zhen Miao,Joshua A Azevedo,EunRan Suh,Vivianna M. Van Deerlin,David Choi,Kathryn Roeder,Mingyao Li,Edward B. Lee +13 more
TL;DR: It is demonstrated that APOE and TREM2 risk variants are associated with a significant reduction in CD163-positive amyloid-responsive microglia, highlighting the diverse microglial response in AD and underscore how genetic risk factors influence cellular responses to underlying pathologies.
Journal ArticleDOI
Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration
Sharon X. Xie,Mark S. Forman,Jennifer M. Farmer,Peachie Moore,Yong Dong Wang,Xuran Wang,Christopher M. Clark,H. B. Coslett,Anjan Chatterjee,Steven E. Arnold,Howard J. Rosen,Jason Karlawish,Vivianna M. Van Deerlin,V M-Y Lee,John Q. Trojanowski,Murray Grossman +15 more
TL;DR: Tau-positive pathology represents a significant risk to survival in FTLD, whereas tau-negative pathology is associated with a longer survival time when clinical MND is excluded.
Journal ArticleDOI
Sensitivity analysis and power for instrumental variable studies.
TL;DR: An approach to sensitivity analysis for the IV method is presented which examines the sensitivity of inferences to violations of IV validity and is based on extending the Anderson-Rubin test and is valid regardless of the strength of the instrument.
Posted ContentDOI
Global-scale CRISPR gene editor specificity profiling by ONE-seq identifies population-specific, variant off-target effects
Karl Petri,Dewey Kim,Kanae E. Sasaki,Matthew C. Canver,Xuran Wang,Hardik Shah,Hang Lee,Joy E. Horng,Kendell Clement,Sowmya Iyer,Sara P. Garcia,Jimin Guo,Gregory A. Newby,Gregory A. Newby,Gregory A. Newby,Luca Pinello,David R. Liu,David R. Liu,David R. Liu,Martin J. Aryee,Kiran Musunuru,Keith Joung J,Pattanayak +22 more
TL;DR: One-Seq as discussed by the authors uses OligoNucleotide Enrichment and sequencing (ONE-seq) to identify off-target sites of gene editors in human cells.